Live Oak Private Wealth’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Hold
13,223
0.03% 188
2025
Q4
$222K Hold
13,223
0.03% 186
2025
Q3
$205K Hold
13,223
0.03% 184
2025
Q2
$169K Hold
13,223
0.03% 185
2025
Q1
$168K Hold
13,223
0.03% 181
2024
Q4
$173K Hold
13,223
0.03% 176
2024
Q3
$199K Sell
13,223
-1,196
-8% -$18.1K 0.03% 171
2024
Q2
$204K Buy
14,419
+41
+0.3% +$554 0.04% 162
2024
Q1
$196K Buy
14,378
+57
+0.4% +$789 0.03% 160
2023
Q4
$193K Hold
14,321
0.04% 159
2023
Q3
$179K Buy
14,321
+28
+0.2% +$368 0.04% 150
2023
Q2
$194K Buy
14,293
+24
+0.2% +$331 0.04% 156
2023
Q1
$199K Buy
14,269
+25
+0.2% +$357 0.04% 154
2022
Q4
$202K Buy
14,244
+1,021
+8% +$14.8K 0.04% 161
2022
Q3
$181K Hold
13,223
0.04% 165
2022
Q2
$188K Hold
13,223
0.04% 167
2022
Q1
$219K Hold
13,223
0.04% 159
2021
Q4
$254K Hold
13,223
0.05% 163
2021
Q3
$275K Hold
13,223
0.06% 155
2021
Q2
$284K Hold
13,223
0.06% 140
2021
Q1
$261K Hold
13,223
0.06% 137
2020
Q4
$261K Hold
13,223
0.07% 128
2020
Q3
$232K Hold
13,223
0.08% 120
2020
Q2
$237K Buy
+13,223
New +$227K 0.09% 118

Other funds holding HQL

Live Oak Private Wealth's HQL Position: Q1 2026 in Review

Live Oak Private Wealth held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 13,223 shares worth $215K. The position accounts for 0.03% of the portfolio, ranked #188.

Live Oak Private Wealth first reported a position in HQL in Q2 2020 and has held it in 24 quarters since. The position peaked at $284K in Q2 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Live Oak Private Wealth held 13,223 shares of abrdn Life Sciences Investors worth $215K as of Q1 2026.
  • Live Oak Private Wealth left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
  • abrdn Life Sciences Investors made up 0.03% of Live Oak Private Wealth's portfolio in Q1 2026, its #188 holding.
  • Live Oak Private Wealth first reported a position in abrdn Life Sciences Investors in Q2 2020 and has held it in 24 quarters since.
  • Live Oak Private Wealth's abrdn Life Sciences Investors position peaked at $284K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Live Oak Private Wealth's 13F filing for Q1 2026, filed 20 Apr 2026.